FDA and CMS work to avert state-federal clash over clinical AI
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
FDA and CMS officials are acting behind the scenes to ease a brewing conflict between states and the federal government over AI in clinical care. The Trump administration has cut regulatory burdens on health AI and added payment routes, but states license medical practice while unsupervised clinical AI such as prescribing likely falls under FDA device rules, creating overlapping jurisdiction.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu